Atara Biotherapeutics, Inc. ($ATRA)
Filing Information
| Accession Number | 0001104659-26-086733 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 25, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
390,482
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 22, 2026 | Exercise/Conversion | 195,211 | โ | โ | 636,912 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Jul 22, 2026 | Tax Withholding | 60 | โ | โ | 636,852 | Indirect | See Footnote | View Details | |
Director | Pre-Funded Warrants to Purchase Common Stock | Derivative | Jul 22, 2026 | Exercise/Conversion | 101,089 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details | |
Director | Pre-Funded Warrants to Purchase Common Stock | Derivative | Jul 22, 2026 | Exercise/Conversion | 38,735 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details | |
Director | Pre-Funded Warrants to Purchase Common Stock | Derivative | Jul 22, 2026 | Exercise/Conversion | 55,387 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details |